Measurement of Procalcitonin in acute exacerbation of COPD and its correlation to Spirometric Indices

Abstract

Background: rational prescription of antibiotics in acute exacerbation of COPD (AECOPD) requires predictive markers. Acute phase reactants are capable of demonstrating the inflammation; however, they cannot be employed to make a difference between bacterial and non-bacterial causes of the inflammation. The bacterial infection plays an important role in the exacerbation of COPD patients. Recently, measurement of serum procalcitonin levels appears to be useful in order to minimize this problem. We aim to evaluate the prognostic and diagnostic Methods & methods: 51 COPD patients with bacterial exacerbations, 47 patients without bacterial exacerbations, similar age and sex were included in the study. PCT levels in the serum samples were measured in all subjects. Results: Procalcitonin levels ranged from 0.01 to 12.03 ng/ml. Mean levels were 3.18±2.60 ng/ml in Group I and 0.23±0.39 ng/ml in Group II. Median values in Groups I and II were 2.98 and 0.09 ng/ml respectively. Statistically, there was a significant difference between two groups (p<0.001) with Group I showing a higher mean value as compared to Group II. A significant near strong correlation was observed between TLC levels and serum Proclacitonin levels (r=0.699; p<0.001). However, a weak negative and borderline significant correlation. Conclusions: This study found increased PCT serum levels among AECOPD patients and suggests a role for PCT in the predicting of the bacterial exacerbations and their needs for ventilator support. We recommend other large studies to augment our findings.

Authors and Affiliations

Ravi Bhaskar| Department of Pulmonary Medicine, Career Institute of Medical Sciences, Lucknow, India, Seema Singh| Department of Respiratory Medicine, King Georges Medical University, Lucknow, India, Pooja Singh| Department of Pulmonary Medicine, Career Institute of Medical Sciences, Lucknow, India, Sandeep K Singh| Guru Ghashidas Vishvhidhalaya, Bilaspur, Chattisgarh, India, Pooja Singh Gaur| Department of Biotechnology, Amity University, Lucknow, India, Sarika Pandey| Department of Respiratory Medicine, King Georges Medical University, Lucknow, India

Keywords

Related Articles

Development and in-vitro evaluation of Furosemide Solid Dispersion using different Water Soluble Carriers

Objective: The objective of the present investigation was to improve solubility and dissolution characteristics of Furosemide, which might offer improved bioavailability. The bioavailability of the drug when taken oral...

HUNTINGTON’S DISEASE: AN INDIAN UPDATE ON GENETICS AND WIDESPREAD

Huntington’s disease (HD) is a dominantly transmitted progressive neurodegenerative disorder due to an abnormal elongation of the polyglutamine (polyQ) chain in the Huntington (Htt) protein. Children of HD gene carrie...

Pharmacological aspects of Turbinaria

Seaweeds, are plant-like organisms that generally live attached to rock or other hard substrata in coastal areas. The brown color of these algae results from the dominance of the xanthophyll pigment fucoxanthin. Brown...

PHARMACOLOGICAL INVESTIGATION OF LEAVES OF ANTHOCEPHALUS CADAMBA (ROXB) FOR HEPATOPROTECTIVE ACTIVITY

The objective of the present investigation was to study hepatoprotective activity of ethanolic extract of leaves of Anthocephalus cadamba, paracetamol induced liver damage model in rats. In this study, liver damage in r...

STUDY ON EFFECTS OF CARBAMAZEPINE AND PHENYTOIN ON DEVELOPMENT OF CHICK EMBRYO

The knowledge about the Teratogenic drugs is crucial while prescribing medications to the pregnant women. Treating epileptic pregnant women is always challenge as most of antiepileptic drugs are potent teratogens and th...

Download PDF file
  • EP ID EP16049
  • DOI http://dx.doi.org/10.21276/IJRDPL.2278-0238.2017.6(6).2833-2
  • Views 336
  • Downloads 16

How To Cite

Ravi Bhaskar, Seema Singh, Pooja Singh, Sandeep K Singh, Pooja Singh Gaur, Sarika Pandey (2017). Measurement of Procalcitonin in acute exacerbation of COPD and its correlation to Spirometric Indices. International Journal of Research and Development in Pharmacy & Life Sciences (IJRDPL), 6(6), 2833-2839. https://europub.co.uk/articles/-A-16049